Martin Celine Christine 4

What Happened Director Martin Celine Christine received an award of 5,603 restricted stock units (RSUs) from CONMED Corporation (CNMD) on 2026-07-01. The RSUs were granted at $0.00 (no cash paid) and are recorded as a derivative grant (code A). The filing shows an acquisition of the contingent rights to 5,603 shares; no common shares were immediately issued or sold.

Key Details

• Transaction date: 2026-07-01; Filing date: 2026-07-02 (filed timely).
• Grant: 5,603 RSUs at $0.00 per unit (derivative award).
• Shares owned after transaction: not reported in the provided data.
• Footnote: Each RSU represents a contingent right to one common share under the Company’s 2025 Long-Term Incentive Plan; RSUs generally vest 100% after one year.
• Transaction code: A = Award/Grant.

Context RSU grants are a form of compensation and do not involve an immediate cash purchase or sale of stock; value is realized only if and when the RSUs vest and convert to shares (then taxed/reported). Such awards are common for executives and directors and are typically part of routine compensation rather than a direct market-confidence signal. Retail investors may watch for future Form 4s showing the issued shares at vesting or any subsequent sales.